To investigate whether CRB3 regulates the tamoxifen sensitivity of breast cancer cells by suppressing tamoxifen‐resistant cells from acquiring stem cell‐like characteristics, we examined cancer stem cell (CSC) properties of breast cancer cells whose CRB3 expression was altered. The gene discussed is CRB3; the disease is breast carcinoma.